All
Managing severe pediatric atopic dermatitis
September 10th 2015Older non-specific immunomodulatory drugs and off-label use of several biologic agents offer treatment options for children with severe atopic dermatitis (AD). However, the future should bring therapies specifically developed for treatment of AD investigated in children.
Quality of life impact of anticancer drugs
September 9th 2015The development of novel targeted anticancer therapies are proving to have a significant impact in the treatment and management of cancer patients; however, these agents also are associated with a distinct set of cutaneous side effects. Learn more.
Step therapy stalls appropriate patient treatment
August 19th 2015Step therapy policies place a large administrative burden on physicians, which, in turn, takes time away from patient care. Some states are working on legislation that seeks to regulate step therapy protocols and ensure they are safe for patients.
Evidence-based guidelines for managing challenging NMSC
August 17th 2015Ongoing research is trying to identify strategies for overcoming resistance of advanced basal cell carcinoma to targeted therapy with a Hedgehog inhibitor. High level evidence to support adjuvant radiotherapy for high-risk non-melanoma skin cancers is lacking, but certain patients warrant evaluation by a multidisciplinary tumor board and treatment with adjuvant radiotherapy based on their risk for recurrence.
What’s new in facial rejuvenation
August 12th 2015From single devices that perform a spectrum of rejuvenation procedures, to older devices that are re-emerging, to new combinations using tried-and-true technologies, dermatologists are at the forefront of what’s new and exciting in facial rejuvenation. Learn more.
Screening labs, complacency, and the ABCDEs of pediatric melanoma
August 11th 2015In part three of our discussion about pediatric dermatology, Kelly Cordoro, M.D., associate professor of dermatology and pediatrics at the University of California in San Francisco, discusses screening labs, avoiding complacency, and the ABCDEs of melanoma with Dermatology Times editorial advisor, Elaine Siegfried, M.D.